Welcome to the Department of Medicine
After Clinical Trial, Baricitinib Approved for Emergency Use
Baricitinib, a drug tested as part of the ACTT trials at Stanford, has been approved by the FDA for emergency use in treating COVID-19 patients.
COVID-19 Grand Rounds and Community Resources
Notes from Leadership
"Today I want to share this video which celebrates some of our brightest moments and highlights all the things that you, our community members, have accomplished"
- Bob Harrington, MD, Department of Medicine Chair